Valeant Pharmaceuticals wants Botox
Ask an Expert
Posted on April 24, 2014
Valeant Pharmaceuticals wants Botox
One of Canada’s largest pharmaceutical companies, Valeant Pharmaceuticals, has unveiled details of its offer to buy Allergan, the maker of Botox, for approximately $45 billion U.S. Lea Katsanis, professor in the Department of Marketing, can weigh in on what this means for the pharmaceutical industry.
Lea Prevel Katsanis – Professor, Department of Marketing
leap@jmsb.concordia.ca
514-848-2424, ext. 2770
Interviews in English only